RAUWOLFIA SERPENTINA Drug Patent Profile
✉ Email this page to a colleague
When do Rauwolfia Serpentina patents expire, and when can generic versions of Rauwolfia Serpentina launch?
Rauwolfia Serpentina is a drug marketed by Bundy, Halsey, Impax Labs, Ivax Sub Teva Pharms, Purepac Pharm, Pvt Form, Solvay, Tablicaps, Valeant Pharm Intl, and Watson Labs. and is included in twelve NDAs.
The generic ingredient in RAUWOLFIA SERPENTINA is rauwolfia serpentina root. There are eight drug master file entries for this compound. Additional details are available on the rauwolfia serpentina root profile page.
Summary for RAUWOLFIA SERPENTINA
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 12 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RAUWOLFIA SERPENTINA at DailyMed |
Recent Clinical Trials for RAUWOLFIA SERPENTINA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |
US Patents and Regulatory Information for RAUWOLFIA SERPENTINA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bundy | RAUWOLFIA SERPENTINA | rauwolfia serpentina root | TABLET;ORAL | 009477-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharm Intl | RAUWOLFIA SERPENTINA | rauwolfia serpentina root | TABLET;ORAL | 009668-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ivax Sub Teva Pharms | RAUWOLFIA SERPENTINA | rauwolfia serpentina root | TABLET;ORAL | 011521-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |